JPRN-jRCT2091220259招募中2 期
Multicenter cooperative and investigator initiated clinical trial using valproic acid in childhood onset spinal muscular atrophy : Continuous administration trial - SMART03
Institute of Medical Genetics, Tokyo Women's Medical University0 个研究点目标入组 28 人开始时间: 2016年8月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 1age old 至 < 8age old（—）
- 性别
- All
入选标准
- •(1) Patients who participate SMART02 study, and who finish 10th visit, which is 32 weeks of SMART02 study.
- •(2) Patients who can visit the hospital as scheduled in clinical trials.
- •(3) Patients with a guardian under conditions below
- •1) A fixed guardian can comprehend the status of the patient and observe the patient's daily activities as required in the clinical trial.
- •2) Management of medicine is definitely possible.
排除标准
- •(1)Patients who have had an operation for spinal scoliosis.
- •(2)Patients on mechanical ventilator with tracheotomy or who are judged to require mechanical ventilation with tracheotomy by the investigator (or sub-investigator).
- •(3)Patient with severe liver dysfunction, renal dysfunction, and circulatory diseases. (judged referring to grade 3 of Severity Criteria for Drug Adverse Reaction Yaku-Ann No 80, issued by the chief of Registration Division the Pharmaceutical Affairs Bureau, Ministry of Welfare)
- •(4)Patients given Riluzole, creatine, butyric acid compound, steroid hormone and sodium valproate within 8 weeks before the agreement was obtained.
- •(5)Patients with malignant tumors
- •(6)Patients with severe medical history of drug allergy such as anaphylactic shock, or serious side effect of drug.
- •(7)Patients participating in other clinical trials except for SMART02 study and administered an investigational new drug within 12 weeks before obtaining the agreement for this clinical trial.
- •(8)Patients scheduled to take a carbapenem antibiotic within the period from agreement to the end of observation.
- •(9)Patients who have started physical therapy for less than four weeks before obtaining the agreement for this clinical trial. Starting the respiratory physical therapy is accepted.
- •(10)Patients with urea cycle abnormalities.
- •(11)Other patients judged to be unsuitable to join this clinical trial by the investigator (or sub-investigator).
研究者
相似试验
已完成
2 期
Multicenter cooperative and investigator initiated clinical trial using valproic acid in childhood onset spinal muscular atrophy : Confirmatory Trialspinal muscular atrophyJPRN-jRCT2091220231Institute of Medical Genetics, Tokyo Women's Medical University28
已完成
2 期
Multicenter cooperative and investigator initiated clinical trial using valproic acid in childhood onset spinal muscular atrophyspinal muscular atrophyJPRN-jRCT2091220190Institute of Medical Genetics, Tokyo Women's Medical University13
已完成
Unknown
A clinical study to assess the safety and efficacy of virtual reality devices that help diagnose Attention-Deficit / Hyperactivity disorder(ADHD)KCT0008403Samsung Changwon Medical Center20
招募中
4 期
Clinical study of Ulinastatin along with standard of care in comparison to standard of care alone (Pooled historical data) in hospitalised moderate COVID-19 patientsCTRI/2021/08/035593Dr Manjunath B G
已完成
1 期
Investigator Initiated Phase 1 Study of TBI-1301JPRN-jRCT2080222844Mie University, Aichi Medical University, Keio University, National Cancer Center Hospital East, National Cancer Center Hospital, National Hospital Organization Nagoya Medical Center12